Q3 2024 saw 6% sales growth, a positive EBITDA, and a record ten new products approved, with royalty and license revenues up 37% on a rolling basis. The company targets 100 MSEK sales and >40% EBITDA margin by 2026.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.